GW Pharmaceuticals PLC reported Tuesday afternoon that sales of its cannabis-derived epilepsy drug more than doubled from the previous quarter, sending shares spiking more than 11% higher in after-hours trading. GW Pharmaceuticals GWPH, +10.22% reported second-quarter sales of $68.4 million for Epidiolex, which uses cannabidiol, a compound present in cannabis plants to treat certain forms of epilepsy. Wall Street […]
Epidiolex
Big Pharma is Coming for the Cannabis Industry
In a recent double-blinded study [1] examining the attitudes of pain specialists and oncologists toward the use of MMJ, only 38% of these physicians in the USA are recommending MMJ to their patients for treating the symptoms of their disease and/or the side effects of their therapy. Furthermore, among those physicians who have never recommended MMJ […]
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress
PRESS RELEASE Epidiolex® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine launched in the U.S. – Conference call today at 4:30 p.m. EST – LONDON and CARLSBAD, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of […]
DEA reclassifies plant-derived marijuana medicine
According to a release issued by the National Organization for the Reform of Marijuana Laws, Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), has been reclassified by the U.S. Drug Enforcement Administration to Schedule V — the lowest restriction classification available under federal law. Epidiolex is the first prescription drug derived from the marijuana plant. […]
First FDA approved cannabis-based drug now available by prescription
The first cannabis-derived medication approved by the Food and Drug Administration is now available by prescription in every state, according to its manufacturer. Epidiolex, manufactured by GW Pharmaceuticals, is intended to treat seizures associated with two rare and severe forms of epilepsy that begin in childhood. The drug is made of cannabidiol (CBD), a component of […]
Will the FDA/DEA Epidiolex Rulings and the 2018 Farm Bill Change the Industry?
In late June 2018, the Food and Drug Administration announced approval for a new medication that could potentially change the way the world views cannabis. Epidiolex is a CBD-based oral solution that is prescribed to treat two forms of rare epilepsy. Patients who suffer from Dravet syndrome, as well as Lennox-Gastaut syndrome, may find that […]
The drug maker behind the first FDA-approved medication derived from marijuana has revealed how much it’ll cost
A marijuana-derived drug that recently became the first of its kind to win federal approval is not going to be cheap. Called Epidiolex, the drug is designed to treat two rare forms of childhood epilepsy using a cannabis compound called cannabidiol (or CBD) . On a call with investors this week, British-based GW Pharmaceuticals, who […]
Buzzkill Alert: California Prohibits Hemp CBD In Food
California is essentially letting the FDA dictate what it will do with hemp CBD. Earlier this month, the California Department of Public Health’s Food and Drug Branch (CDPH-FDB) issued a revised FAQ on cannabidiol (CBD) in food products. Per these FAQs it appears California intends to block the sale of hemp-derived CBD products — which are […]
The Federal Government has acknowledged a patent on a cannabis based pharmaceutical as a legitimate and useful medicine
G.W. Pharmaceuticals accomplished a feat that is about to change the course of history. They achieved drug approval for a plant-based medicine related to cannabis for treatment of certain conditions in children! This doesn’t apply only to states that have legal adult use or medical cannabis. It goes a long way to answering the question […]
The FDA Just Approved the First-Ever Cannabis Based Drug in the U.S.
The Food and Drug Administration (FDA) for the first time approved a drug directly derived from cannabis on Monday, Epidiolex, developed by the British GW Pharmaceuticals. Although several states have legalized the medical and recreational use of marijuana, the federal agency had yet to do so until today. Under the Controlled Substances Act, marijuana is […]
